Hospital
Porter Hospital LLC
Porter Hospital LLC was paid $28.17M by Medicaid between Jan 2018 and Dec 2024, across 101 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoPORTER HOSPITAL LLC
VALPARAISO, IN 46383
VALPARAISO, IN 46383
33aNPI1215151154assigned 04/12/2007
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.17M
24GClaims439,057
24DCodes billed101
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Indiana
Rank by total paid#14 of 69
Median peer was paid$9.76M
This provider vs. median2.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LALOR, PAULA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 65,407 | $1.43M | |
| 2019 | 49,098 | $2.55M | |
| 2020 | 37,098 | $2.27M | |
| 2021 | 65,227 | $4.90M | |
| 2022 | 86,372 | $6.60M | |
| 2023 | 79,061 | $6.14M | |
| 2024incomplete | 56,794 | $4.29M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 60,596 | 50,934 | $8.75M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 39,205 | 31,196 | $5.59M |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 10.0% | 6,163 | 1,960 | $2.81M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 6.8% | 16,142 | 14,700 | $1.92M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.4% | 7,552 | 5,938 | $965K |
| 71045 | Radiologic examination, chest; single view | 3.2% | 7,556 | 5,893 | $893K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.0% | 3,595 | 2,418 | $854K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.5% | 12,844 | 8,759 | $711K |
| 71046 | Radiologic examination, chest; 2 views | 2.3% | 5,022 | 4,226 | $636K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1.9% | 7,720 | 6,642 | $524K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.6% | 2,845 | 2,507 | $443K |
| 80050 | General health panel | 1.3% | 3,097 | 2,798 | $374K |
89 more codes
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.2% | 2,032 | $330K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1.1% | 897 | $324K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,324 | $267K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 4,356 | $229K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 572 | $224K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,275 | $209K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 2,090 | $208K |
| 80053 | Comprehensive metabolic panel | <1% | 38,468 | $194K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 49,704 | $181K |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 1,728 | $177K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 5,736 | $158K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 918 | $119K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,204 | $117K |
| 36415 | Collection of venous blood by venipuncture | <1% | 63,543 | $114K |
| 76820 | <1% | 1,804 | $92K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 835 | $88K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 742 | $71K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 989 | $67K |
| 84484 | <1% | 7,582 | $48K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,599 | $45K |
| 81025 | <1% | 7,536 | $40K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 6,362 | $39K |
| 87430 | <1% | 2,809 | $33K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 996 | $31K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,270 | $30K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 694 | $29K |
| 83690 | <1% | 8,761 | $27K | |
| 81001 | <1% | 15,169 | $26K | |
| 96367 | <1% | 302 | $15K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 55 | $14K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,773 | $14K |
| 59025 | Fetal non-stress test | <1% | 65 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,374 | $13K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 47 | $11K |
| 87081 | <1% | 1,906 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 2,904 | $10K |
| 82077 | <1% | 740 | $8K | |
| 11043 | <1% | 26 | $8K | |
| 99218 | <1% | 14 | $8K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 47 | $6K |
| 87400 | <1% | 317 | $6K | |
| 80074 | <1% | 138 | $6K | |
| 96417 | <1% | 51 | $5K | |
| 87807 | <1% | 377 | $4K | |
| 80061 | Lipid panel | <1% | 551 | $4K |
| 83735 | <1% | 897 | $4K | |
| 81003 | <1% | 2,450 | $3K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 20 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 468 | $2K |
| 87806 | <1% | 131 | $2K | |
| 87070 | <1% | 339 | $2K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 16 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 21 | $2K |
| 80076 | <1% | 209 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 169 | $1K |
| 85027 | <1% | 165 | $921.22 | |
| 86592 | <1% | 227 | $856.89 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 35 | $806.40 |
| 85610 | <1% | 432 | $523.43 | |
| 86140 | <1% | 99 | $333.07 | |
| 36591 | <1% | 242 | $274.16 | |
| 85379 | <1% | 44 | $267.73 | |
| 82728 | <1% | 30 | $205.83 | |
| 84153 | <1% | 13 | $181.15 | |
| 80069 | <1% | 124 | $128.65 | |
| 87040 | <1% | 23 | $124.81 | |
| 82570 | <1% | 67 | $122.13 | |
| 84460 | <1% | 55 | $101.74 | |
| 85730 | <1% | 56 | $101.13 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 22 | $100.02 |
| 84450 | <1% | 55 | $99.45 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 39 | $77.85 |
| 82550 | <1% | 16 | $71.61 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,559 | $68.26 |
| 82043 | <1% | 34 | $65.61 | |
| 82247 | <1% | 16 | $58.44 | |
| 82962 | <1% | 38 | $37.88 | |
| 84156 | <1% | 17 | $21.95 | |
| 81015 | <1% | 12 | $21.35 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 273 | $18.30 |
| J2704 | Injection, propofol, 10 mg | <1% | 3,243 | $14.62 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,872 | $1.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 101 | $0.00 |
| 99152 | 0% | 73 | $0.00 | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 16 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 108 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 162 | $0.00 |
| C1769 | Guide wire | 0% | 37 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLALOR, PAULA (DIRECTOR/DELEGATED OFFICIAL)
| Provider | Location | Paid |
|---|---|---|
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
| Victoria of Texas LP | Victoria, TX | $7.74M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.